- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
已发现中线卖出信号。
- 长期趋势：
已有191家主力机构披露2025-12-31报告期持股数据，持仓量总计5.16亿股，占流通A股27.38%
- 波段诊断：
-
技术面诊股
诊断结果：2.2技术面打败了7%的股票
技术面评分前10的股票
近期的平均成本为4.19元。空头行情中，并且有加速下跌的趋势。已发现中线卖出信号。
平均成本
近期的平均成本为4.19元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"4.19","date":1782201431,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2026.06.24","stock":"0.00","trade":"-0.89","ind":"1.24"},{"date":"2026.06.23","stock":"0.72","trade":"3.68","ind":"-3.17"},{"date":"2026.06.22","stock":"0.73","trade":"0.07","ind":"2.13"},{"date":"2026.06.18","stock":"-1.90","trade":"0.66","ind":"0.94"},{"date":"2026.06.17","stock":"-2.55","trade":"-1.16","ind":"1.31"},{"date":"2026.06.16","stock":"-2.27","trade":"-0.99","ind":"0.93"},{"date":"2026.06.15","stock":"0.87","trade":"0.15","ind":"3.79"},{"date":"2026.06.12","stock":"1.54","trade":"2.07","ind":"0.75"},{"date":"2026.06.11","stock":"0.00","trade":"-1.24","ind":"-0.68"},{"date":"2026.06.10","stock":"2.02","trade":"-0.14","ind":"-2.06"},{"date":"2026.06.09","stock":"2.29","trade":"0.45","ind":"3.02"},{"date":"2026.06.08","stock":"-2.24","trade":"-2.49","ind":"-3.22"},{"date":"2026.06.05","stock":"0.00","trade":"0.25","ind":"-2.21"},{"date":"2026.06.04","stock":"-1.98","trade":"-1.80","ind":"-0.27"},{"date":"2026.06.03","stock":"-0.66","trade":"-1.10","ind":"0.73"},{"date":"2026.06.02","stock":"-1.08","trade":"-2.06","ind":"1.63"},{"date":"2026.06.01","stock":"2.21","trade":"0.40","ind":"-1.51"},{"date":"2026.05.29","stock":"0.89","trade":"0.36","ind":"-1.81"},{"date":"2026.05.28","stock":"-0.44","trade":"-0.71","ind":"0.80"},{"date":"2026.05.27","stock":"-1.96","trade":"-1.05","ind":"-0.88"},{"date":"2026.05.26","stock":"0.22","trade":"-1.43","ind":"0.12"}]
华邦健康,深证成指,化学制药指数
压力支撑
该股压力位为4.18元，支撑位为4.11元。
[{"text":"\u538b\u529b\u4f4d","value":"4.18","date":1782230400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"4.11","date":1782230400,"color":"0x0b52a1"}]
多空趋势
空头行情中，并且有加速下跌的趋势。已发现中线卖出信号。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.0资金面打败了20%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体无进出。
更新时间：06月24日 20:30
| 机构今日流向(万元) | -301.27 | 机构5日流向(万元) | 124.92 |
| 机构10日流向(万元) | -1174.93 | 机构20日流向(万元) | -9792.23 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量增加866.05万股，其中基金净减仓3家，主力净增仓57家，请投资者中长期谨慎为宜。
截止2025-12-31，共191家主力机构（基金187家，阳光私募1家，一般法人3家），持仓量总计51567.11万股，占流通A股27.38%
其中，基金持仓与2025-06-30相比：
增仓：32家 ，增持 587.57万股
减仓：35家 ，减持 379.19万股
新出现在主力名单中：118家 ，持有3616.41万股
从主力名单中消失：61家 ，原持有3921.83万股
其中，基金持仓与2025-06-30相比：
增仓：32家 ，增持 587.57万股
减仓：35家 ，减持 379.19万股
新出现在主力名单中：118家 ，持有3616.41万股
从主力名单中消失：61家 ，原持有3921.83万股
消息面诊股
诊断结果：5.6消息面打败了11%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 现金分红陆续出炉！36股连续三年股息率超3%
2026-06-24 - 603165，股息率近15%！连续三年股息率超3%
2026-06-24 - 华邦健康：本次事项暂未对公司整体经营造成重大不利影
2026-06-22 - 华邦健康：努力推动投资价值合理反应公司质量
2026-06-22 - 华邦健康：6月18日获融资买入411.88万元
2026-06-22 - 华邦健康控股股东解除质押2540万股股份
2026-06-21 - 争议未了！税务稽查横跨6年，华邦健康子公司申辩后仍
2026-06-18 - 争议未了！税务稽查横跨6年，华邦健康子公司申辩后仍
2026-06-17 - 华邦健康：重庆汇邦卓远科技有限公司质押2250.0
2026-06-17 - 华邦健康：未来将依法依规运用各类方式提升公司投资价
2026-06-17
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-06-17 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-06-06 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-05-29 |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-23 |
| 利好 | 分红转增 | 10派2.5元(含税) | 2026-04-23 |
| 一般消息 | 高管变动 | 由于个人原因 | 2026-04-17 |
| 利好 | 业绩预告 | 预计扭亏 | 2026-01-21 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-14 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-13 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-06 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-10-28 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-27 |
| 利好 | 分红转增 | 10派2元(含税) | 2025-08-20 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 5条 | 0条 | 5条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：6.5行业面打败了93%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2026.06.24","price":"1.24","value":"-0.89"},{"date":"2026.06.23","price":"-3.17","value":"3.68"},{"date":"2026.06.22","price":"2.13","value":"0.07"},{"date":"2026.06.18","price":"0.94","value":"0.66"},{"date":"2026.06.17","price":"1.31","value":"-1.16"},{"date":"2026.06.16","price":"0.93","value":"-0.99"},{"date":"2026.06.15","price":"3.79","value":"0.15"},{"date":"2026.06.12","price":"0.75","value":"2.07"},{"date":"2026.06.11","price":"-0.68","value":"-1.24"},{"date":"2026.06.10","price":"-2.06","value":"-0.14"},{"date":"2026.06.09","price":"3.02","value":"0.45"},{"date":"2026.06.08","price":"-3.22","value":"-2.49"},{"date":"2026.06.05","price":"-2.21","value":"0.25"},{"date":"2026.06.04","price":"-0.27","value":"-1.80"},{"date":"2026.06.03","price":"0.73","value":"-1.10"},{"date":"2026.06.02","price":"1.63","value":"-2.06"},{"date":"2026.06.01","price":"-1.51","value":"0.40"},{"date":"2026.05.29","price":"-1.81","value":"0.36"},{"date":"2026.05.28","price":"0.80","value":"-0.71"},{"date":"2026.05.27","price":"-0.88","value":"-1.05"},{"date":"2026.05.26","price":"0.12","value":"-1.43"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 花园生物 | 54.50% | 27.84% | 4.9分 |
| 2 | 富祥股份 | 42.54% | 26.64% | 6.2分 |
| 3 | 灵康药业 | 36.02% | 21.10% | 6.8分 |
| 4 | 纳微科技 | 25.13% | 13.98% | 6.3分 |
| 5 | 海欣股份 | 24.11% | 32.59% | 4.8分 |
| 6 | 贝达药业 | 22.92% | 16.62% | 6.5分 |
| 8 | 海辰药业 | 14.59% | 26.28% | 5.1分 |
| 10 | 亨迪药业 | 12.02% | 21.01% | 4.8分 |
| 12 | 科伦药业 | 6.73% | 4.44% | 5.3分 |
| 14 | 百利天恒 | 4.52% | 5.36% | 5.5分 |
| 16 | 新华制药 | 3.88% | 15.27% | 4.7分 |
| 18 | 赛分科技 | 3.42% | -3.58% | 6.1分 |
| 20 | - | 2.71% | 5.36% | 分 |
| 22 | 恒瑞医药 | 2.55% | 6.12% | 6.3分 |
| 24 | 天宇股份 | 2.14% | 9.44% | 6.0分 |
| 26 | - | 2.03% | 17.85% | 分 |
| 28 | 华特达因 | 1.49% | 1.16% | 5.3分 |
| 30 | 吉贝尔 | 1.19% | 4.21% | 4.9分 |
| 32 | 泽璟制药 | 1.06% | 10.08% | 5.9分 |
| 34 | 圣诺生物 | 0.44% | 7.22% | 5.4分 |
| 36 | 威尔药业 | -0.62% | 3.08% | 5.4分 |
| 38 | 力生制药 | -1.07% | 1.17% | 5.5分 |
| 40 | 北陆药业 | -1.08% | 7.98% | 5.4分 |
| 42 | 津药药业 | -1.19% | 4.40% | 4.5分 |
| 44 | - | -1.40% | 1.02% | 分 |
| 46 | 健康元 | -1.68% | 0.50% | 4.6分 |
| 48 | 普洛药业 | -2.32% | 2.87% | 5.5分 |
| 50 | 双鹭药业 | -2.36% | 12.19% | 4.6分 |
| 52 | 亚太药业 | -2.43% | 9.32% | 4.3分 |
| 54 | - | -2.57% | 4.66% | 分 |
| 56 | 前沿生物 | -2.81% | 13.56% | 5.8分 |
| 58 | 复星医药 | -2.89% | 2.97% | 4.6分 |
| 60 | ST人福 | -3.02% | 0.24% | 4.2分 |
| 62 | 华润双鹤 | -3.52% | -1.79% | 4.9分 |
| 64 | 华邦健康 | -3.91% | -3.02% | 4.2分 |
| 66 | 北大医药 | -4.07% | -4.60% | 4.6分 |
| 68 | 辰欣药业 | -4.44% | 1.21% | 4.4分 |
| 70 | 哈三联 | -4.73% | -3.99% | 4.2分 |
| 72 | ST能特 | -5.24% | -1.36% | 4.7分 |
| 74 | 恩华药业 | -5.56% | -0.58% | 4.4分 |
| 76 | 兴齐眼药 | -5.80% | 6.85% | 5.6分 |
| 78 | - | -5.88% | 3.57% | 分 |
| 80 | 福安药业 | -6.35% | -1.12% | 4.3分 |
| 82 | 金城医药 | -6.44% | 4.33% | 5.4分 |
| 84 | 京新药业 | -6.47% | 1.97% | 5.3分 |
| 86 | 国药现代 | -6.62% | -1.89% | 4.9分 |
| 88 | 天新药业 | -6.96% | -2.57% | 4.3分 |
| 90 | 德展健康 | -7.01% | 0.66% | 4.3分 |
| 92 | 哈药股份 | -7.14% | 0.00% | 4.3分 |
| 94 | 华仁药业 | -7.80% | -0.76% | 4.1分 |
| 96 | 永安药业 | -7.82% | -0.36% | 4.3分 |
| 98 | 华海药业 | -7.94% | 3.23% | 5.0分 |
| 100 | 凯因科技 | -8.41% | -0.62% | 4.7分 |
| 102 | 海森药业 | -8.94% | -6.49% | 3.9分 |
| 104 | 九典制药 | -9.06% | 0.49% | 4.3分 |
| 106 | 新天地 | -9.22% | 1.54% | 4.1分 |
| 108 | 泰恩康 | -10.13% | -5.07% | 4.2分 |
| 110 | 益方生物 | -10.31% | 5.14% | 5.4分 |
| 112 | 溢多利 | -10.44% | 2.42% | 4.2分 |
| 114 | 司太立 | -10.68% | 2.09% | 5.1分 |
| 116 | 易明医药 | -11.15% | -4.28% | 4.8分 |
| 118 | 西点药业 | -11.19% | 0.31% | 4.4分 |
| 120 | 誉衡药业 | -12.25% | 0.38% | 4.5分 |
| 122 | 富士莱 | -12.45% | -2.79% | 4.2分 |
| 124 | 健友股份 | -12.85% | -2.33% | 4.9分 |
| 126 | 尔康制药 | -13.38% | 0.56% | 4.5分 |
| 128 | 汇宇制药 | -13.49% | 0.46% | 5.3分 |
| 130 | 翰宇药业 | -13.61% | -4.74% | 4.7分 |
| 132 | 联环药业 | -14.13% | -4.75% | 4.4分 |
| 134 | 必贝特 | -14.18% | 6.79% | 5.5分 |
| 136 | ST复华 | -15.05% | -6.14% | 3.5分 |
| 138 | 广济药业 | -15.64% | -4.08% | 3.6分 |
| 140 | 莎普爱思 | -16.05% | -4.97% | 4.3分 |
| 142 | 莱美药业 | -17.27% | -9.80% | 4.1分 |
| 144 | 亚虹医药 | -17.37% | -5.11% | 4.5分 |
| 146 | 中哲精化 | -18.81% | -3.86% | 4.3分 |
| 148 | 冀衡医药 | -19.86% | -12.15% | 3.7分 |
| 150 | 奥翔药业 | -21.07% | -4.26% | 4.2分 |
| 152 | 迪哲医药 | -26.47% | 7.74% | 5.5分 |
| 154 | *ST赛隆 | -28.14% | -22.65% | 4.2分 |
| 156 | 上海谊众 | -29.10% | 1.62% | 5.1分 |
| 158 | 博瑞医药 | -33.45% | -12.31% | 4.2分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 70/218 ， 99/218。
[{"date":"2026-03-31","value":"1.50","vol":"0.43"},{"date":"2025-12-31","value":"7.29","vol":"-2.03"},{"date":"2025-09-30","value":"6.43","vol":"1.53"},{"date":"2025-06-30","value":"4.07","vol":"1.24"},{"date":"2025-03-31","value":"1.95","vol":"-0.13"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.50 | 7.29 | 6.43 | 4.07 | 1.95 |
| 行业(%) | 0.43 | -2.03 | 1.53 | 1.24 | -0.13 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"35.87","vol":"50.72"},{"date":"2025-12-31","value":"36.92","vol":"49.72"},{"date":"2025-09-30","value":"37.01","vol":"49.60"},{"date":"2025-06-30","value":"36.28","vol":"49.57"},{"date":"2025-03-31","value":"37.12","vol":"49.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
35.87 | 36.92 | 37.01 | 36.28 | 37.12 |
| 行业(%) | 50.72 | 49.72 | 49.60 | 49.57 | 49.06 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 78/218 ， 94/218。
[{"date":"2026-03-31","value":"-0.08","vol":"25.51"},{"date":"2025-12-31","value":"-1.31","vol":"38.97"},{"date":"2025-09-30","value":"1.98","vol":"141.63"},{"date":"2025-06-30","value":"0.39","vol":"78.56"},{"date":"2025-03-31","value":"-3.24","vol":"0.01"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-0.08 | -1.31 | 1.98 | 0.39 | -3.24 |
| 行业(%) | 25.51 | 38.97 | 141.63 | 78.56 | 0.01 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-16.01","vol":"47.13"},{"date":"2025-12-31","value":"338.53","vol":"-26.11"},{"date":"2025-09-30","value":"35.37","vol":"-2.93"},{"date":"2025-06-30","value":"23.90","vol":"59.61"},{"date":"2025-03-31","value":"18.50","vol":"-10.40"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-16.01 | 338.53 | 35.37 | 23.90 | 18.50 |
| 行业(%) | 47.13 | -26.11 | -2.93 | 59.61 | -10.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 74/218 ， 28/218。
[{"date":"2026-03-31","value":"0.10","vol":"0.10"},{"date":"2025-12-31","value":"0.39","vol":"0.41"},{"date":"2025-09-30","value":"0.31","vol":"0.31"},{"date":"2025-06-30","value":"0.20","vol":"0.21"},{"date":"2025-03-31","value":"0.10","vol":"0.10"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.10 | 0.39 | 0.31 | 0.20 | 0.10 |
| 行业(次) | 0.10 | 0.41 | 0.31 | 0.21 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.92","vol":"0.65"},{"date":"2025-12-31","value":"3.40","vol":"2.58"},{"date":"2025-09-30","value":"2.68","vol":"1.93"},{"date":"2025-06-30","value":"1.71","vol":"1.29"},{"date":"2025-03-31","value":"0.78","vol":"0.66"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.92 | 3.40 | 2.68 | 1.71 | 0.78 |
| 行业(次) | 0.65 | 2.58 | 1.93 | 1.29 | 0.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"7.61","vol":"-2.81"},{"date":"2025-12-31","value":"39.74","vol":"16.49"},{"date":"2025-09-30","value":"18.96","vol":"4.26"},{"date":"2025-06-30","value":"15.96","vol":"2.95"},{"date":"2025-03-31","value":"1.34","vol":"-26.33"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 7.61 | 39.74 | 18.96 | 15.96 | 1.34 |
| 行业 | -2.81 | 16.49 | 4.26 | 2.95 | -26.33 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.56","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.59","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.56 | - | 0.59 | - |
| 行业 | 0.00 | 1.60 | 0.00 | 1.71 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 44/218 ， 5/218。
[{"date":"2026-03-31","value":"1.40","vol":"3.57"},{"date":"2025-12-31","value":"1.26","vol":"3.31"},{"date":"2025-09-30","value":"1.34","vol":"3.48"},{"date":"2025-06-30","value":"1.23","vol":"3.66"},{"date":"2025-03-31","value":"1.14","vol":"3.57"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
1.40 | 1.26 | 1.34 | 1.23 | 1.14 |
| 行业 | 3.57 | 3.31 | 3.48 | 3.66 | 3.57 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.94","vol":"2.93"},{"date":"2025-12-31","value":"0.78","vol":"2.69"},{"date":"2025-09-30","value":"0.91","vol":"2.73"},{"date":"2025-06-30","value":"0.86","vol":"2.88"},{"date":"2025-03-31","value":"0.74","vol":"2.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
0.94 | 0.78 | 0.91 | 0.86 | 0.74 |
| 行业 | 2.93 | 2.69 | 2.73 | 2.88 | 2.80 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 29/218 ， 28/218。
[{"date":"2026-03-31","value":"41.89","vol":"33.54"},{"date":"2025-12-31","value":"41.51","vol":"34.70"},{"date":"2025-09-30","value":"44.95","vol":"34.06"},{"date":"2025-06-30","value":"46.17","vol":"34.12"},{"date":"2025-03-31","value":"47.30","vol":"34.09"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
41.89 | 41.51 | 44.95 | 46.17 | 47.30 |
| 行业(%) | 33.54 | 34.70 | 34.06 | 34.12 | 34.09 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.20","vol":"9.77"},{"date":"2025-12-31","value":"1.18","vol":"1.76"},{"date":"2025-09-30","value":"1.36","vol":"1.19"},{"date":"2025-06-30","value":"1.40","vol":"0.87"},{"date":"2025-03-31","value":"1.48","vol":"1.44"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.20 | 1.18 | 1.36 | 1.40 | 1.48 |
| 行业(%) | 9.77 | 1.76 | 1.19 | 0.87 | 1.44 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"4.33","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"3.02","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-2.99","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"7.13","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]